Tag: IHC

Get up to speed with the latest trends and developments in digital pathology – Join Visiopharm at this year’s Pathology Visions, Oct 1-3, San Diego, California

| August 22, 2017 | 0 Comments

During the event, we will be showcasing our entire digital pathology portfolio. Here we are particularly proud to share our work in advancing PD-L1 testing based on the patented VirtualTripleStaining™ and its utility in automated assessment of Ki-67 in breast cancers.  In addition, you will be able to see examples from our new HER2 quality […]

Continue Reading

OptraSCAN Digital Pathology Launches On-Demand Image Analysis Suite at USCAP 2017

| March 6, 2017 | 0 Comments

Affordable and scanner agnostic image analysis solutions utilizing artificial intelligence for colorimetric and morphometric analysis for oncology, neuroscience and toxicological pathology SUNNYVALE, CA–(BUSINESS WIRE)—OptraSCAN, Inc. today announced the launch of its next generation, On-Demand suite of image analysis software for digital pathology, which includes OptraASSAYSTM, CARDSTM and OptraPROCESSTM. The image analysis suite supports both individual, […]

Continue Reading

Slidematch™ now features Alignment of Brightfield and Fluorescence Whole Slide Images

| February 20, 2017 | 0 Comments

Munich, 20 February 2017 — microDimensions launches a new version of its high precision whole slide alignment software Slidematch. With the new version users can align digital whole slide images from consecutive sections in brightfield and fluorescence mode, e.g. for the evaluation of the HER2 status of cancer patients.  While brightfield images (e.g. stained in […]

Continue Reading

Immunoscore® Colon is available as a CE-IVD solution

| January 5, 2017 | 0 Comments

Immunoscore® Colon is the first standardized immune‐based assay for the classification of cancers Immunoscore® has been validated by the Immunoscore® worldwide consortium, led by the SITC (ASCO 2016) Immunoscore® is a superior predictor of survival than microsatellite instability Marseille, France, January 5, 2017 – HalioDx SAS, an independent immuno-oncology diagnostic company, today announced that its […]

Continue Reading

Flagship Biosciences Customizes Assay Development and Tissue Image Analysis for Advanced Cell Diagnostics RNAscope Platform

| April 18, 2015 | 0 Comments

April 16, 2015, Westminster CO — Flagship Biosciences, the leading service provider of digital pathology solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope® RNA in situ hybridization (ISH) from Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecularpathology and developer of […]

Continue Reading

Accuracy of HER2 Testing in Gastric Cancer

| April 5, 2015 | 0 Comments

With almost 1 million new cases per year, gastric cancer is currently the number four most common malignant disease. Today, there is no universal standard treatment. Recently, however, the ToGA trial demonstrated efficacy of Trastuzumab (Herceptin) for gastric and gastro-oesophageal (G/GEJ) patients who are over-expressing HER2. In 2010, the FDA approved Trastuzumab for treatment of […]

Continue Reading

Join Definiens at Molecular Med Tri-Con 2015, February 16-18 in San Francisco, CA

| February 1, 2015 | 0 Comments

Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At the conference we will be showcasing the latest imaging and analysis technologies which are revolutionizing research pathology, leading to breakthroughs in personalized medicine […]

Continue Reading

Applied Spectral Imaging receives FDA Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67

| January 22, 2015 | 0 Comments

Carlsbad, CA. – January 21, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis platform. ASI’s GenASIs HiPath IHC Family is an advanced image analysis platform for IHC and CISH samples that integrates with existing lab […]

Continue Reading

Join Applied Spectral Imaging at CAP’14 – THE Pathologists’ Meeting in Chicago, Il, USA September 7- 9, 2014

| September 2, 2014 | 0 Comments

Join ASI in booth # 223 at CAP’14 – THE Pathologists’ Meeting Come see ASI’s GenASIs HiPath, the latest Pathology Quantitative Diagnostic Aid, providing solutions for any sized lab! Ask questions from our experts, see a demo and get a comprehensive overview of our platform. GenASIs HiPath provides computer aided scoring and reporting for quantitative […]

Continue Reading

Join PerkinElmer at the 26th European Congress of Pathology in London– August 30 – September 3, 2014

| August 10, 2014 | 0 Comments

Visit our booth (#37) at ECP to learn how our quantitative pathology solutions can help analyze complex relationships among tumor and immune cells in the tumor micro-environment. Our imaging systems and reagent solutions can deliver per-cell quantitative protein expression from up to 8 markers, giving data similar to that obtained from flow cytometry, but from […]

Continue Reading

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope

| July 25, 2014 | 0 Comments

ASI’s Webinar – July 29, 2014 – Register Now – Digital Pathology On Your Microscope A complete solution for FISH, CISH and IHC Applied Spectral Imaging Inc. develops computer aided image analysis & diagnostic tools for clinical and research applications. The GenASIs platform integrates within the existing workflow of the microscope, pathologist and LIS framework, […]

Continue Reading

Register now for Leica Biosystems’ next FREE Pathology Leaders™ Webinar: IHC Work-Up for Carcinoma of Unknown Origin

| June 18, 2014 | 0 Comments

Register now for Leica Biosystems’ next FREE Pathology Leaders™ Webinar: “IHC Work-Up for Carcinoma of Unknown Origin” Wednesday, June 25, 2014 10:00 am and 1:00 pm CST/4:00 pm and 7:00 pm GMT IHC Work-Up for Carcinoma of Unknown Origin Join Regan Fulton, M.D, PhD. Director of Contract Research and Staff Pathologist at PhenoPath Laboratories. Wednesday, […]

Continue Reading

CAP: Medicare IHC Payment Policy is Inappropriate for Services Provided to Patients

| February 12, 2014 | 0 Comments

The College of American Pathologists (CAP) has sent a letter to Ms. Clara Marie Smith (CMS) on behalf of Mickey Doyle (MD) in response to the reimbursement cuts now in effect for immunohistochemistry (IHC), essentially claiming that they don’t know anything about IHC services in its version of Kindergarten Coloring – Rules 88342 and 88343 painting […]

Continue Reading

Philips receives FDA clearance for Digital Manual Read of HER2 pathology slides

| October 17, 2013 | 0 Comments

Philips introduces clinical digital imaging product for pathologists. 510(k) clearance from the US Food and Drug Administration (FDA) allows Philips to market its Her2/neu IHC Digital Manual Read product in the US. Pathologists can now use a digital system from Philips to help them assess treatment options for breast cancer patients. Royal Philips (NYSE: PHG, […]

Continue Reading